Skip to content

Measles Vaccination Cash Incentives Experimental Evidence From Nigeria

Measles Vaccination Cash Incentives Experimental Evidence From Nigeria

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04013516
Enrollment
1088
Registered
2019-07-09
Start date
2017-05-12
Completion date
2017-09-11
Last updated
2019-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Measles

Keywords

Immunization, Incentives

Brief summary

IDinsight is conducting a randomized controlled trial to assess the impact of various sized cash incentives for caretakers of infants that require a 9-month measles vaccination on the completion rate for the vaccine in Nigeria. The purpose of the experiment is to help New Incentives (NI) determine the optimal size of the incentive as they scale to the North West region of Nigeria.

Interventions

BEHAVIORALCash Incentive

During the phone call, New Incentives' team member promised a greater cash payment from New Incentives' staff members at primary health care facilities when infants enrolled in the program and received their measles vaccination.

BEHAVIORALCall

A New Incentives' team member reminded caregivers of their child's measles immunization date and the total amount of incentive they would receive once their child was vaccinated. If the caregiver could not be reached on the first attempt, the team made additional attempts at different times of the day on five different days across two weeks (up to 10 attempts were made per caregiver).

Sponsors

GiveWell
CollaboratorOTHER
IDinsight
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Participants randomly assigned to different incentive amounts (treatment arms), a pure control arm, and a placebo arm which consisted of a phone call without an additional incentive.

Eligibility

Sex/Gender
ALL
Age
9 Months to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Caregiver and infant registered with the New Incentives program * The infant was nine months or older at the start of the study (note there was no upper age limit as New Incentives only began enrolling infants in October 2016) * Infant had received at least one previous conditional cash transfer for immunization at an All Babies are Equal Initiative clinic, * Infant had received their Penta-3 vaccine. * The caregiver had provided a phone number (either a personal number or a number of someone who can reach them) during registration.

Exclusion criteria

* Infant had already received a measles vaccine

Design outcomes

Primary

MeasureTime frameDescription
Measles Vaccination Coverage RateWe assessed whether eligible infants received measles vaccination at any time during the 4 month study period. Children were a minimum of 9 months at the beginning of the study and a maximum of 7 years at the end of the study.The outcome of interest is the measles coverage rate among the eligible randomized infants. Coverage is measured using the measles vaccination information recorded on the child's health card. The child health card information was immediately entered into the New Incentives' database by their field staff when they disbursed the cash incentives at program clinics. Information from the New Incentives' database was used for the analysis.

Countries

Nigeria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026